These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7411549

  • 1. Tumor inhibitory triazenes. 2. Variation of antitumor activity within an homologous series.
    Wilman DE, Goddard PM.
    J Med Chem; 1980 Sep; 23(9):1052-4. PubMed ID: 7411549
    [Abstract] [Full Text] [Related]

  • 2. Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity.
    Wilman DE, Cox PJ, Goddard PM, Hart LI, Merai K, Newell DR.
    J Med Chem; 1984 Jul; 27(7):870-4. PubMed ID: 6737430
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide.
    Earl RA, Townsend LB.
    J Med Chem; 1979 Nov; 22(11):1422-5. PubMed ID: 533891
    [Abstract] [Full Text] [Related]

  • 4. Preparation and antitumor activity of 1-aryl-3,3-dimethyltriazene derivatives.
    Giraldi T, Nisi C, Connors TA, Goddard PM.
    J Med Chem; 1977 Jun; 20(6):850-3. PubMed ID: 874961
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Varnavas A, Nisi C, Lassiani L, Sava G, Perissin L, Boccù E.
    Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
    Colombo T, D'Incalci M.
    Cancer Chemother Pharmacol; 1984 Nov; 13(2):139-41. PubMed ID: 6467499
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and antitumor activity of halogen-substituted 4-(3,3-dimethyl-1-triazeno)quinolines.
    Lin AJ, Loo TL.
    J Med Chem; 1978 Mar; 21(3):268-72. PubMed ID: 628002
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, physicochemical properties, and antitumor activities of analogs of 1-phenyl-3-benzyl-3-methyltriazenes.
    Dunn WJ, Greenberg MJ.
    J Pharm Sci; 1977 Oct; 66(10):1416-9. PubMed ID: 21950
    [Abstract] [Full Text] [Related]

  • 9. Studies of the mode of action of antitumour triazenes and triazines-II. Investigation of the selective toxicity of 1-aryl-3,3-dimethyltriazenes.
    Gescher A, Hickman JA, Simmonds RJ, Stevens MF, Vaughan K.
    Biochem Pharmacol; 1981 Jan 01; 30(1):89-93. PubMed ID: 7213416
    [No Abstract] [Full Text] [Related]

  • 10. Tumour inhibitory triazenes: structural requirements for an active metabolite.
    Connors TA, Goddard PM, Merai K, Ross WC, Wilman DE.
    Biochem Pharmacol; 1976 Feb 01; 25(3):241-6. PubMed ID: 1267820
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.
    Heyes J, Catherall EJ, Cockburn A.
    Cancer Chemother Rep; 1973 Feb 01; 57(3):263-8. PubMed ID: 4751253
    [No Abstract] [Full Text] [Related]

  • 18. Use of cluster analysis in the development of structure-activity relations for antitumor triazenes.
    Dunn WJ, Greenberg MJ, Callejas SS.
    J Med Chem; 1976 Nov 01; 19(11):1299-301. PubMed ID: 1003406
    [Abstract] [Full Text] [Related]

  • 19. [Depression of the immune response to lymphoma allotransplant with the use of 5-(3,3-dimethyl-1-triazeno)-imidazol-4-carboxamide (DTIC)].
    Giampietri A, Puccetti P, Circolo A, Menconi E.
    Boll Soc Ital Biol Sper; 1977 Jun 15; 53(11):922-6. PubMed ID: 597414
    [No Abstract] [Full Text] [Related]

  • 20. Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.
    Beal DD, Skibba JL, Croft WA, Cohen SM, Bryan GT.
    J Natl Cancer Inst; 1975 Apr 15; 54(4):951-7. PubMed ID: 1127724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.